Vistaprint Progresses on Turnaround and 4 Stock Analyses Buzzing Today

MakeMyTrip Limited (NASDAQ:MMYT) saw a 6.6 percent boost yesterday as a result of a report claiming that Abu Dhabi’s Etihad Airways is considering buying a stake in India’s Kingfisher Airlines, influencing Oppenheimer to think that such a deal could potentially keep Kingfisher afloat as it leads the way for other foreign airlines to invest in their Indian counterparts. A development like this may potentially cause passenger volumes to see a rise and benefit MakeMyTrip along with additional Indian online travel agencies, according to the Oppenheimer. The firm keeps its Outperform rating on the stock.

Vistaprint N.V. (NASDAQ:VPRT): After the firm met with Vistaprint’s CEO, Cantor is convinced that the company has begun to make slow but steady progress on its turnaround. The firm believes that the stock’s risk is limited, and it keeps its Buy rating on the stock.

Are you worried about the Fiscal Cliff? Click here to get our Gold & Silver Premium Newsletter OVER 50% OFF now!

Netflix, Inc. (NASDAQ:NFLX): Morgan Stanley continues to be positive regarding Netflix’s new deal with Disney (NYSE:DIS), and the firm is convinced that the deal provides more negotiation leverage with other studios when it comes time to renew. The firm gives the stock an Overweight rating.

CROCS Inc. (NASDAQ:CROX): After meeting with management, Goldman continues to be positive regarding Croc’s repurchase activity, and it continues to be confident in its earnings outlook. The firm keeps its Buy rating and $17 on the stock.

Celgene Corporation (NASDAQ:CELG) recently updated Phase III data about its pomalidomide cancer drug, influencing Stifel to believe that the drug will be approved by the FDA in February. The firm believes that the drug will generate sales reaching $594 million during 2015, and it keeps its Buy rating on the stock.

Don’t Miss: Larry Page Wants an Apple Romance.